(Q37991396)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397588%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Recent advances in the therapeutic applications of pyrazolines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397588%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author

Abdelrahman S. Mayhoub

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397588%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Ahmad M. Farag

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397588%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Mohamed R Shaaban

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397588%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

English

0 references

publication date

8 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397588%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Patents

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397588%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397588%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397588%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

253-291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397588%20AND%20SRC:MED&resulttype=core&format=json

Extraction and determination of 2-pyrazoline derivatives using liquid phase microextraction based on solidification of floating organic drop.

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Fluorescence polarization study of human erythrocyte membranes with 1-phenyl-3-(2-naphthyl)-2-pyrazoline as orientational probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Study on the fluorescence properties of a new intramolecular charge transfer compound 1,5-diphenyl-3-(N-ethylcarbazole-3-yl)-2-pyrazoline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Biological activities of pyrazoline derivatives--a recent development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Novel 3,4-diarylpyrazolines as potent cannabinoid CB1 receptor antagonists with lower lipophilicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Diaryl dihydropyrazole-3-carboxamides with significant in vivo antiobesity activity related to CB1 receptor antagonism: synthesis, biological evaluation, and molecular modeling in the homology model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Pyrazoline bearing benzimidazoles: search for anticancer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Inhibition of amine oxidases activity by 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Design, synthesis, and biological testing of pyrazoline derivatives of combretastatin-A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Cooperative E-box regulation of human GLI1 by TWIST and USF

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Blocking Hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and anticancer activity of isatin-based pyrazolines and thiazolidines conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

TGF-beta induces the expression of the FLICE-inhibitory protein and inhibits Fas-mediated apoptosis of microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Anticonvulsant activity and selective inhibition of nicotinamide adenine dinucleotide-dependent oxidations by 1,3,5-trisubstituted pyrazolines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2''-hydroxy naphthalen-1''-yl)-1,5-diphenyl-2-pyrazolines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

PSYCHOPHARMACOLOGY:Can the Placebo Be the Cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

New pyrazoline derivatives and their antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Pyrazoline-based mycobactin analogues as MAO-inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Facile synthesis of bis(4,5-dihydro-1H-pyrazole-1-carboxamides) and their thio-analogues of potential PGE(2) inhibitory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Pyrogenic immunomodulators increase the level of prostaglandin E2 in the blood simultaneously with the onset of fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Novel bis(1-acyl-2-pyrazolines) of potential anti-inflammatory and molluscicidal properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and pharmacological evaluation of pyrazoline derivatives as new anti-inflammatory and analgesic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and antiinflammatory activity of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and antiinflammatory activity of heterocyclic indole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and pharmacological study of 1-acetyl/propyl-3-aryl-5-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-pyrazoline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and pharmacological evaluation of a novel series of 5-(substituted)aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines as novel anti-inflammatory and analgesic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and investigation of anti-inflammatory activity and gastric ulcerogenicity of novel nitric oxide-donating pyrazoline derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and antinociceptive activities of some pyrazoline derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Alpha 2-adrenoceptors and 5-HT receptors mediate the antinociceptive effect of new pyrazolines, but not of dipyrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and antimicrobial activity of 1-(4-aryl-2-thiazolyl)-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-pyrazoles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and biological activity of some new pyrazoline and pyrrolo[3,4-c]pyrazole-4,6-dione derivatives: reaction of nitrilimines with some dipolarophiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Small molecules with structural similarities to siderophores as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis: implications for treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis, antitubercular activity and docking study of novel cyclic azole substituted diphenyl ether derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis, characterization, antiamoebic activity and cytotoxicity of novel series of pyrazoline derivatives bearing quinoline tail

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Syntheses and evaluation of 3-(3-bromo phenyl)-5-phenyl-1-(thiazolo [4,5-b] quinoxaline-2-yl)-2-pyrazoline derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Novel Pd(II) complexes of 1-N-substituted 3-phenyl-2-pyrazoline derivatives and evaluation of antiamoebic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis, spectral studies and antiamoebic activity of new 1-N-substituted thiocarbamoyl-3-phenyl-2-pyrazolines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and antiamoebic activities of 1-N-substituted cyclised pyrazoline analogues of thiosemicarbazones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and antiamoebic activity of new 1-N-substituted thiocarbamoyl-3,5-diphenyl-2-pyrazoline derivatives and their Pd(II) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Bis-pyrazolines: synthesis, characterization and antiamoebic activity as inhibitors of growth of Entamoeba histolytica

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and antiviral activity of new pyrazole and thiazole derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and evaluation of in vitro antiviral activity of novel phenoxy acetic acid derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Triaryl pyrazoline compound inhibits flavivirus RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Identification of compounds with anti-West Nile Virus activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) synthesis, degradation, and translocation by high-density lipoprotein(2) at a low concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Novel 3,5-diaryl pyrazolines as human acyl-CoA:cholesterol acyltransferase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

4,5-dihydro-1H-pyrazole derivatives with inhibitory nNOS activity in rat brain: synthesis and structure-activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Discovery of non-steroidal mifepristone mimetics: pyrazoline-based PR antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis and antiandrogenic activity of some new 3-substituted androstano[17,16-c]-5'-aryl-pyrazoline and their derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Action of pyrazoline-type insecticides at neuronal target sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.667403

Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives

21 January 2018

1 reference

12 December 2020

[Relation between glucose tolerance and depression and its therapy using monoamine oxidase inhibitors and lithium salts]

1 reference

12 December 2020

Syntheses, characterization and in vitro antiamoebic activity of new Pd(II) complexes with 1-N-substituted thiocarbamoyl-3,5-diphenyl-2-pyrazoline derivatives

1 reference

12 December 2020

Synthesis of some thiazolyl-pyrazoline derivatives and preliminary investigation of their hypotensive activity

1 reference

12 December 2020

Prostaglandin E2 in the pathogenesis of pyrogen fever: validation of an intermediary role

1 reference

12 December 2020

MAO inhibitors in chronic pain and depression

1 reference

12 December 2020

A clinical study of the selective MAO-A-inhibitor moclobemide (Ro 11-1163): a comparison of 2 different dosages with particular reference to platelet MAO-activity and urinary MHPG-excretion.

1 reference

12 December 2020

Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1 H )-pyrazole derivatives

1 reference

12 December 2020

A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics

1 reference

12 December 2020

TGF beta 1 induces caspase-dependent but death-receptor independent apoptosis in lymphoid cells

1 reference

12 December 2020

Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives

1 reference

12 December 2020

Synthesis and antimicrobial studies on novel chloro-fluorine containing hydroxy pyrazolines

1 reference

12 December 2020

Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3-(4'-hydroxy-3'-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines

1 reference

12 December 2020

Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme.

1 reference

12 December 2020

Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazole derivatives

1 reference

12 December 2020

Combination of tricyclic antidepressants and MAOI in the depressions

1 reference

12 December 2020

An improved synthesis of 1,3,5-triaryl-2-pyrazolines in acetic acid aqueous solution under ultrasound irradiation

1 reference

12 December 2020

TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase

1 reference

12 December 2020